UNITAID’s Market Approach in HIV Diagnostics
UNITAID approach to working in markets to improve public health
UNITAID Operations Report to EB12
The Medicines Patent Pool - Stimulating Innovation, Improving access
Better Diagnostics Are Needed to Achieve an AIDS-Free Generation
The HIV/AIDS Diagnostic Landscape: What does the Future Hold?
TB AND DR-TB IN SOUTH AFRICA: SIZE, PROGRESS AND CONTINUING CHALLENGES
MARKET-BASED APPROACHES FOR PUBLIC HEALTH IN THE GLOBALIZATION ERA
TUBERCULOSIS ACCESS ISSUES THE KEY CHALLENGES IN MDR-TB
CREATING NEW PARADIGMS OF COUNTRY-DONOR MARKET APPROACHES FOR PUBLIC HEALTH: THE CASE OF MULTI-DRUG RESISTANT TUBERCULOSIS AND THE CRITICAL ROLE OF BRICS
SOCIAL PROTECTION INTERVENTIONS FOR TB CONTROL: THE BRAZILIAN EXPERIENCE
Market impact of WHO selection and prequalification of priority medicines
The Importance of Market Interventions to Achieve the Goals of Treatment 2.0
Using modelling to inform our diagnostics strategy
Pilot Implementation of Point-Of-Care, CD4 Counting in Mozambique’s National Health System
Evolving markets require evolving market approaches
UNITAID Strategy 2013-2016, Executive Summary
Tuberculosis medicines technology and market landscape - 1st edition
UNITAID Impact 2012
Malaria diagnostics technology landscape - semi-annual update